These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 5285940

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Rubella vaccination during an epidemic.
    Furukawa T, Miyata T, Kondo K, Kuno K, Isomura S, Takekoshi T.
    JAMA; 1970 Aug 10; 213(6):987-90. PubMed ID: 5468562
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. "Rubella virus vaccine, live".
    Clin Pediatr (Phila); 1970 Dec 10; 9(12):15A passim. PubMed ID: 5487471
    [No Abstract] [Full Text] [Related]

  • 26. Neutralizing antibodies after rubella vaccination of newly delivered women: a comparison between three vaccines.
    Grillner L.
    Scand J Infect Dis; 1975 Dec 10; 7(3):169-72. PubMed ID: 1237176
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Exposure of susceptible pregnant women to rubella vaccinees. Serologic findings during the Rhode Island immunization campaign.
    Scott HD, Byrne EB.
    JAMA; 1971 Jan 25; 215(4):609-12. PubMed ID: 5107437
    [No Abstract] [Full Text] [Related]

  • 29. Vaccination of infants with HPV-77 vaccine.
    Pavilanis V, Chagnon A, Davignon L, Joncas J.
    Am J Dis Child; 1969 Aug 25; 118(2):247-51. PubMed ID: 4978509
    [No Abstract] [Full Text] [Related]

  • 30. Vaccination with RA 27-3 rubella vaccine. Persistence of immunity and resistance to challenge after two years.
    Liebhaber H, Ingalls TH, Le Bouvier GL, Horstmann DM.
    Am J Dis Child; 1972 Feb 25; 123(2):133-6. PubMed ID: 4554549
    [No Abstract] [Full Text] [Related]

  • 31. [Changes in antibody titre after rubella vaccination in primarily rubella-sera positive parturient women. Demonstration of antigen-specific (rubella) and non-specific stimulated antibody titres (author's transl)].
    Doerr HW, Geisen HP, Kapp M, Schmidt W.
    Dtsch Med Wochenschr; 1980 Sep 19; 105(38):1316-20. PubMed ID: 6257468
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A survey of rubella antibodies in health personnel and a report of vaccine trial.
    Snell E, Stackiw W, Wilt JC.
    Can Med Assoc J; 1971 Feb 06; 104(3):206-9. PubMed ID: 5539728
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Test of anti-rubella vaccination with live and attenuated virus (Cendehill strain)].
    Leogrande G, Barnaba L, Iandolo E, Iatta E.
    Minerva Med; 1970 Apr 14; 61(30 Suppl):1595-8. PubMed ID: 4378365
    [No Abstract] [Full Text] [Related]

  • 38. Vaccination of schoolgirls against rubella. Assessment of serological status and a comparative trial of Wistar RA 27/3 and Cendehill strain live attenuated rubella vaccines in 13-year-old schoolgirls in Dudley.
    Freestone DS, Reynolds GM, McKinnon JA, Prydie J.
    Br J Prev Soc Med; 1975 Dec 14; 29(4):258-61. PubMed ID: 766879
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.